5 Insights on

• Reduced Caries Lesions
• Reduced Caries Risk
• No Mutagenicity, Teratogenicity, or Genotoxicity
• Reduced Streptococcus mutans Recoveries
• Absence of Toxicity

3 Insights on

• Increased Butyrate Production
• Reduced Clostridia Cluster XIV
• Increased Propionic Acid Production

4 Insights on

• Reduced Salivary Levels of Mutans Streptococci
• Reduced Mutans Streptococcus Counts
• Reduced Streptococcus Mutans Levels
• Reduced Salivary S. mutans Count

4 Insights on

• Improved Natural Killer Cell Activity
• Reduced Risk of Common Cold
• Improved Quality of Life for Eye, Nose, and Throat Symptoms
• Improved Quality of Life for Eye Health

4 Insights on

• Ensured Safety for Human Consumption
• Absence of Genotoxicity
• Absence of Subacute Toxicity
• No Adverse Health Effects in Animal Study

5 Insights on

• Reduced Low-Density Lipoprotein Level
• Reduced Liver Triglyceride Content
• Reduced Serum Total Cholesterol
• Reduced Triglycerides
• Reduced Liver Cholesterol Levels

1 Insight on

• Reduced Bowel Movements

4 Insights on

• Improved Gastrointestinal Health
• Improved Immune Function
• Improved Immune Response
• Improved Bioavailability

1 Insight on

• Reduced Urogenital Infections

9 Insights on

• Increased PMN Cell Phagocytic Capacity
• Reduced Hepatic Oxidative Stress
• Increased Anti-Inflammatory Cytokine IL-10
• Modulated Cytokine Production
• Improved Immune Surveillance
• Reduced PMN Cell Migration Towards Inflammatory Mediators
• Increased Expression of Activation Markers on NK Cells
• Improved PHA-Induced Cytokine Production
• Increased Cytokine Production

11 Insights on

• Reduced Waist Circumference
• Reduced Body Mass Index
• Reduced Body Weight
• Reduced Abdominal Fat
• Increased Adiponectin Levels
• Reduced Hip Circumference
• Reduced Visceral Fat Mass
• Reduced Abdominal Visceral Fat
• Reduced Abdominal Subcutaneous Fat
• Reduced BMI
• Increased Serum High-Molecular Weight Adiponectin

8 Insights on

• Reduced Tumor Growth
• Increased Interleukin-12 Production
• Reduced Transforming Growth Factor Beta Levels
• Enhanced Delayed-Type Hypersensitivity Response
• Reduced Tumor Growth Rate
• Increased IL-12 Production in Splenocytes
• Increased IL-12 Production
• Improved Delayed-Type Hypersensitivity Response

3 Insights on

• Increased Lactate Levels
• Improved Protein Digestion
• Reduced Intestinal Symptoms from Carbohydrate Sensitivity

2 Insights on

• Reduced Duration of Diarrhea
• Resolution of Diarrhea

5 Insights on

• Reduced C-Reactive Protein Levels
• Improved Pain Management
• Improved Functional Capacity
• Improved Pain Scale
• Increased Functional Capacity

4 Insights on

• Reduced Gastrointestinal Symptoms
• Improved Quality of Life
• Reduced Abdominal Pain
• Reduced Abdominal Distension

4 Insights on

• Improved Gut Microbiota
• Increased Propionic Acid Levels
• Increased Atopobium Growth
• Reduced Butyrate Production

3 Insights on

• Increased Mortality Rate
• Increased Antimicrobial Resistance
• Moderate High-Level Gentamicin Resistance

2 Insights on

• Increased Fecal Spore Counts
• Maintained Digestive Function

2 Insights on

• Reduced Upper Respiratory Tract Infection Days
• Reduced Duration of Infectious Diseases

4 Insights on

• Reduced Triglyceride Levels
• Reduced Oxidative Damage in Serum
• Reduced Lipid Peroxidation
• Increased Paraoxonase 1 Enzyme Activity

3 Insights on

• Protection Against Induced Colon Cancer
• Reduced Risk of Colorectal Cancer
• Reduced Colon Cancer Risk

2 Insights on

• Reduced IL-8 Production in Gastric Epithelial Cells
• Reduced Expression of Cag Pathogenicity Island Genes in H. pylori

1 Insight on

• Heterologous Protein Secretion

5 Insights on

• Reduced Periodontopathic Bacteria
• Reduced Tannerella Forsythia Levels
• Improved Periodontal Health
• Reduced Tannerella forsythia in Subgingival Plaque
• Reduced Pathogenic Bacteria

2 Insights on

• Reduced Vaginal Colonization by Probiotic Lactobacillus
• Increased Vaginal Colonization by Lactobacillus crispatus CTV-05

20 Insights on

• Improved Gut Microbiota
• Reduced Total Cholesterol Levels
• Reduced Low-Density Lipoprotein Level
• Reduced Triglyceride Levels
• Reduced LDL Cholesterol
• Stable High-Density Lipoprotein Cholesterol Level
• Reduced Liver Triglyceride Content
• Increased Fecal Cholesterol Levels
• Reduced Serum Total Cholesterol
• Reduced Triglycerides Level
• No Change in E. coli Count
• Reduced Liver Triglycerides
• Reduced Triglycerides
• Reduced Liver Cholesterol
• Increased Bifidobacterium Levels in Feces
• Increased Fecal Lactic Acid Bacteria Counts
• Reduced Escherichia coli Population
• No Change in HDL Cholesterol
• Increased Fecal Triglyceride Levels
• Stable Escherichia coli Population in Fecal Matter

4 Insights on

• Reduced Serum OVA-specific IgE Levels
• Reduced Serum IgE Levels
• Reduced Serum OVA-specific IgG1 Levels
• Modulated Systemic Th1/Th2 Balance

6 Insights on

• Reduced Intestinal Cell Adhesion
• Enhanced Antimicrobial Resistance
• Gastrointestinal Survival
• Increased Intestinal Cell Adhesion
• Increased Antimicrobial Resistance
• Survival Through Human Intestine

7 Insights on

• Improved Bowel Movement Frequency
• Improved Stool Consistency
• Increased Stool Frequency
• Improved Defecation Condition
• Improved Stool Frequency
• Normal Safety Parameters
• Maintained Food Intake